Trimetazidine Dihydrochloride Tablets

DRUG4 trials

Sponsors

Jun Li, Guang'anmen Hospital of China Academy of Chinese Medical Sciences, Sara Refaat Azab Metry

Conditions

Chinese Herbal MedicineCoronary Artery Disease(CAD)Coronary Heart DiseaseDiabetic Peripheral Neuropathic Pain (DPN)Unstable Angina

Phase 1

Effect of Trimetazidine on Endothelin-1 and Clinical Outcomes of Patients With Diabetic Peripheral Neuropathy

RecruitingNCT07794475

Sara Refaat Azab MetryDiabetic Peripheral Neuropathic Pain (DPN)

Start: 2026-08-01End: 2027-02-01Target: 60Updated: 2026-08-31

Phase 4

Curative Effect Evaluation of Shexiang Baoxin Pill on Coronary Artery Disease Not Amenable to Revascularization

Jun LiCoronary Artery Disease(CAD)

Start: 2017-06-30End: 2019-02-28Target: 440Updated: 2017-04-04

Curative Effect Evaluation of Danlou Tablet on Coronary Artery Disease Not Amenable to Revascularization

Jun LiCoronary Artery Disease(CAD)

Start: 2017-06-30End: 2019-02-28Target: 440Updated: 2017-04-04

Efficacy and Safety of Wen Xin Granules for the Treatment of Unstable Angina Pectoris

Guang'anmen Hospital of China Academy of Chinese Medical SciencesCoronary Heart Disease, Unstable Angina, Chinese Herbal Medicine

Start: 2021-03-01End: 2023-06-01Target: 502Updated: 2021-01-25

Related Papers

Efficacy and safety of Chinese herbal medicine Wen Xin granules for the treatment of unstable angina pectoris with Yang deficiency and blood stasis syndrome: study protocol for a randomized controlled trial

Trials2021-11-131 citations

Efficacy and safety of the Shexiang Baoxin Pill for the treatment of coronary artery disease not amenable to revascularisation: study protocol for a randomised, placebo-controlled, double-blinded trial

BMJ Open2018-02-0113 citations